EDGAR Filing Documents for 0000929638-24-002002

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000929638-24-002002

Filing Date

2024-05-29

Accepted

2024-05-29 18:12:54

Documents

Period of Report

2024-05-28

Document Format Files

Seq	Description	Document	Type	Size
1		form4.html	4
1		form4.xml	4	5201
	Complete submission text file	0000929638-24-002002.txt		6658

Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8

Business Address

Glickman Richard M (Reporting) CIK: 0001352637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41854 | Film No.: 241000062

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1

Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888

enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)